超声引导下肩胛上神经连续射频消融治疗骨关节炎继发慢性肩痛:回顾性队列研究
回顾性分析2013年10月至2020年1月接受超声引导下肩胛上神经连续射频消融的101例骨关节炎继发慢性肩痛患者(共127次首次手术),采用冈盂切迹远端选择性消融并联合运动感觉刺激保护运动支;消融后24小时和2周VAS疼痛评分均显著改善,重复治疗不常需要,结论认为该治疗安全有效。
要点
- 超声引导下冈盂切迹处肩胛上神经连续射频消融是骨关节炎继发慢性肩痛的安全治疗方法,重复治疗不常需要。
- 操作在超声引导下完成,不使用电离辐射。
- 联合运动与感觉刺激确认电极位置,保护肩胛上神经运动支免受消融。
核心结论
- 超声引导下冈盂切迹处肩胛上神经连续射频消融是骨关节炎继发慢性肩痛的安全治疗方法,重复治疗不常需要,并与VAS疼痛评分显著改善相关。
研究设计与样本
- 回顾性队列研究,纳入2013年10月至2020年1月接受超声引导下肩胛上神经连续射频消融的101例骨关节炎继发慢性肩痛患者,共127次首次消融手术;术中将射频电极置于冈盂切迹肩胛上神经远端关节支处,用运动和感觉刺激确认位置,在3个不同点、每点80°C、每次1分钟、最多消融3次。
诊断标准与关键数值
- 消融前平均VAS疼痛评分为7.7,消融后24小时平均VAS评分为4.4,消融后2周平均VAS评分为4.5。
- 消融前曾行119次诊断性超声引导下肩胛上神经皮质类固醇注射,注射前平均VAS评分为8.3,注射后24小时平均VAS评分为4.4,注射后2周平均VAS评分为4.5。
临床应用与阅片要点
- 操作在超声引导下完成,不使用电离辐射。
- 射频电极置于冈盂切迹肩胛上神经远端关节支处,用运动和感觉刺激确认位置以保护运动支。
- 连续射频消融在3个不同点进行,每点80°C、1分钟,最多3次。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: The objective of this study is to retrospectively evaluate the use of ultrasound-guided continuous radiofrequency (CRF) lesioning of the suprascapular nerve for treating chronic shoulder pain, due to osteoarthritis. We describe a modified distal and selective ablation technique in the spinoglenoid notch, with motor and sensory stimulation, which protects the motor branch of the nerve from ablation.
METHODS: A retrospective analysis was performed of patients, who underwent ultrasound-guided CRF lesioning of the suprascapular nerve from October 2013 to January 2020. During the procedure, the CRF electrode is placed in the spinoglenoid notch, at the distal suprascapular nerve capsular branch. Motor and sensory stimulations are used to confirm the position. CRF lesioning is applied up to three times, at 3 different points, for 1 min each time, at 80° C.
RESULTS: In total, 127 first CRF suprascapular nerve lesioning procedures were performed on 101 patients with chronic shoulder pain secondary to osteoarthritis. One hundred nineteen diagnostic ultrasound-guided suprascapular nerve corticosteroid injections were performed prior to ablation. Mean pre-injection Visual Analogue Scale pain score (VAS) was 8.3, with post-injection VAS score of 4.4 at 24 h and 4.5 at 2 weeks. Mean pre-CRF lesioning VAS pain score was 7.7 with post-CRF lesioning VAS score of 4.4 at 24 h and 4.5 at 2 weeks.
CONCLUSIONS: Ultrasound-guided CRF lesioning of the suprascapular nerve in the spinoglenoid notch is a safe treatment for chronic osteoarthritic shoulder pain, with repeat treatments infrequently required. It is associated with significant improvement in VAS pain scores.
KEY POINTS: • Ultrasound-guided continuous radiofrequency lesioning of the suprascapular nerve in the spinoglenoid notch is a safe treatment for chronic shoulder pain in degenerative disease, with repeat treatments infrequently required. • The procedure is performed under ultrasound guidance, without the use of ionising radiation.
引用
- Mermekli, Reddy, McKean, et al. Ultrasound-guided continuous radiofrequency ablation of the suprascapular nerve for chronic shoulder pain secondary to osteoarthritis: a retrospective cohort study. Eur Radiol. 2022. PMID: 35389048. doi:10.1007/s00330-022-08763-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。